Codexis Revenue Jumps 91 Percent in Q2
Codexis ( NASDAQ:CDXS ) , a biotechnology company specializing in enzyme engineering for pharmaceutical manufacturing, released its second quarter 2025 results on August 13, 2025. The headline news was an increase in revenue ( GAAP ) to $15.3 million, above analyst expectations of $14.09 million ...
Codexis ( CDXS ) Reports Q2 Loss, Tops Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of +5.88% and +2.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BioXcel Therapeutics, Inc. ( BTAI ) Reports Q2 Loss, Lags Revenue Estimates
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Kymera Therapeutics, Inc. ( KYMR ) Reports Q2 Loss, Misses Revenue Estimates
Kymera Therapeutics (KYMR) delivered earnings and revenue surprises of -14.46% and -66.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Specialty Enzymes Market to Reach $9.2 Billion by 2029, Driven by Biotech Innovation and Public Funding
Delray Beach, FL, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- According to a research report published by MarketsandMarkets, "Specialty Enzymes Market by Source ( Microorganism, Plant, Animal ) , Type ( Carbohydrases, Proteases, Lipases, Polymerases & Nucleases ) , Application ( Pharmaceuticals, ...
Vertex Pharmaceuticals ( VRTX ) Surpasses Q2 Earnings and Revenue Estimates
Vertex (VRTX) delivered earnings and revenue surprises of +6.60% and +2.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Regeneron ( REGN ) Tops Q2 Earnings and Revenue Estimates
Regeneron (REGN) delivered earnings and revenue surprises of +60.52% and +9.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - Codexis ( NASDAQ:CDXS )
Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases Management to host conference call today at 8 am Eastern Time to discuss data REDWOOD CITY, Calif., May 22, 2025 ( GLOBE NEWSWIRE ) -- ...
Codexis to Participate in Jefferies Global Healthcare Conference
REDWOOD CITY, Calif., May 21, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 3-5, ...
Codexis ( CDXS ) Reports Q1 Loss, Misses Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of -25% and 28.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Dare Bioscience, Inc. ( DARE ) Reports Q1 Loss, Lags Revenue Estimates
Dare Bioscience (DARE) delivered earnings and revenue surprises of 20.63% and 95.83%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Immunome, Inc. ( IMNM ) Reports Q1 Loss, Tops Revenue Estimates
Immunome (IMNM) delivered earnings and revenue surprises of 21.21% and 28.33%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Codexis ( CDXS ) Expected to Beat Earnings Estimates: Should You Buy?
Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NovoCure ( NVCR ) Reports Q1 Loss, Tops Revenue Estimates
NovoCure (NVCR) delivered earnings and revenue surprises of 34.04% and 5.03%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Bringing clarity and precision to the cell-free space by introducing exozymes
Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduces the terms 'exozymes' to bring clarity to the rapidly evolving field of cell-free biomanufacturing-a biomanufacturing method to produce chemicals ...
Codexis Announces Byron Dorgan to Retire from Board of Directors
REDWOOD CITY, Calif., April 09, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that Byron Dorgan will retire from the Company's Board of Directors when his current term ...
Arcutis Biotherapeutics ( ARQT ) Moves 10.8% Higher: Will This Strength Last?
Arcutis Biotherapeutics (ARQT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services - Codexis ( NASDAQ:CDXS )
Represents first project to enter the ECO Synthesis™ Innovation Lab Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain REDWOOD CITY, Calif., March 24, 2025 ( GLOBE NEWSWIRE ) -- ...
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., March 07, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to two new employees as approved by the Compensation ...
Codexis ( CDXS ) Reports Q4 Loss, Misses Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of -550% and 26.65%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Codexis Announces New Employment Inducement Grants - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to five new employees as approved by the Compensation Committee of Codexis' ...
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to five new employees as approved by the Compensation ...
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for the fourth quarter and fiscal year 2024 on Thursday, ...
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th
REDWOOD CITY, Calif., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for the fourth quarter and fiscal year 2024 on ...
Alkermes ( ALKS ) Q4 Earnings and Revenues Surpass Estimates
Alkermes (ALKS) delivered earnings and revenue surprises of 28.40% and 13.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
North America Leads Specialty Enzymes Market Amid Rising Demand for Diagnostics and Therapeutics
Delray Beach, FL, Feb. 04, 2025 ( GLOBE NEWSWIRE ) -- According to MarketsandMarkets, the global specialty enzymes market is projected to grow significantly, with its size estimated to reach $6.1 billion in 2024 and further expanding to $9.2 billion by 2029, recording a compound annual growth ...
Codexis Appoints Christos Richards to Board of Directors - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Jan. 16, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Christos Richards to the Company's Board of Directors.
Codexis Announces New Employment Inducement Grants - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Jan. 10, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to two new employees as approved by the Compensation Committee of Codexis' ...
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Jan. 10, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to two new employees as approved by the Compensation Committee ...
Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer - Caribou Biosciences ( NASDAQ:CRBU )
BERKELEY, Calif., Jan. 02, 2025 ( GLOBE NEWSWIRE ) -- Caribou Biosciences, Inc. CRBU, a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Sri Ryali as chief financial officer, effective immediately.
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Dec. 06, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to five new employees as approved by the Compensation ...
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Nov. 19, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Piper Sandler 36th Annual Healthcare Conference, being held December 3-5, ...
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 19, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Piper Sandler 36th Annual Healthcare Conference, being held ...
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Nov. 12, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Raymond De Vré, PhD, to the Company's Board of Directors.
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics - Codexis ( NASDAQ:CDXS )
-Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset- -Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type enzymes- -Management to host conference call on Thursday, November 14 to discuss data-
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
-Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic ...
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Nov. 08, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of an equity grant to one new employee as approved by the Compensation ...
Codexis ( CDXS ) Reports Q3 Loss, Tops Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of -16% and 10.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Oct. 24, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will have three data presentations at the upcoming TIDES Europe annual meeting, being held ...
Codexis Announces New Employment Inducement Grants - Codexis ( NASDAQ:CDXS )
REDWOOD CITY, Calif., Oct. 14, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to eight new employees as approved by the Compensation Committee of Codexis' ...
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Oct. 14, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to eight new employees as approved by the Compensation ...
Codexis to Report Third Quarter 2024 Financial Results on October 31
REDWOOD CITY, Calif., Oct. 10, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for the third quarter of 2024 on Thursday, October ...
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company - Codexis ( NASDAQ:CDXS )
Company raises $31 million through ATM, bringing cash runway into 2027 New additions to leadership in technical operations, finance and intellectual property prepare Codexis for the next phase of growth REDWOOD CITY, Calif., Oct. 02, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc.
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
Company raises $31 million through ATM, bringing cash runway into ...
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and diagnostic applications Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes ...
Strength Seen in Rhythm Pharmaceuticals ( RYTM ) : Can Its 7.4% Jump Turn into More Strength?
Rhythm Pharmaceuticals (RYTM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Sept. 06, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading enzyme engineering company, today announced the approval of equity grants to three new employees as approved by the Compensation Committee of Codexis' Board of Directors.
Codexis to Participate in Upcoming Healthcare Conferences
REDWOOD CITY, Calif., Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading enzyme engineering company, today announced that management will participate in two upcoming investor conferences.
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
REDWOOD CITY, Calif., Aug. 20, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading enzyme engineering company, today announced the Company will participate in a presentation and panel discussion at the upcoming RNA Leaders annual meeting, being held September 4-5, 2024, in San ...
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Aug. 16, 2024 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading enzyme engineering company, today announced the approval of equity grants to three new employees as approved by the Compensation Committee of Codexis' Board of Directors.
